National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Vacancies
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
COVID-19
For Patients
Drugs
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
R
S
T
U
V
Z
Brentuximab vedotin (Adcetris®) for CD30+ cutaneous T-cell lymphoma (CTCL)
Brentuximab vedotin (Adcetris®) for CD30+ Hodgkins lymphoma HTA ID: 19058
Brentuximab vedotin (Adcetris®). HTA ID: 21010
Brigatinib (Alunbrig®)
Brigatinib (Alunbrig®) HTA ID: 20031
Brimonidine 3.3 mg/g gel (Mirvaso®)
Brivaracetam (Briviact®)
Brodalumab (Kyntheum®)
Brolucizumab (Beovu®). HTA ID: 20009
Budesonide orodispersible tablet (Jorveza®)
« First
Previous Page
...
6
7
8
9
10
11
12
13
14
15
...
30
40
50
...
Next Page
Last »
health check